Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.

ABSTRACT:

Background

Medicaid recipients have a high burden of opioid overdose and opioid use disorder (OUD). Opioid agonist therapies are an effective treatment for OUD, but there is a wide and persisting gap between those who are indicated and those who receive treatment. The objective of this study was to identify the predictors of enrollment in opioid agonist therapy within 6 months of an opioid overdose or OUD diagnosis in a cohort of Medicaid recipients.

Methods

Using multiple linked, state-level databases, we conducted a retrospective cohort study of 17,449 Medicaid recipients in Rhode Island who had an opioid overdose or an OUD diagnosis between July 2013 and June 2018.

Results

The majority (58 %) of Medicaid recipients did not enroll in opioid agonist therapy within 6

SUBMITTER: Macmadu A 

PROVIDER: S-EPMC7855664 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature